# Implementation Status, Scientific Scope Boundaries & Benchmark Report - EVOCURE v1.0.0

This document fulfills Section 28 Deliverables **#18 (Implemented Features Report)**, **#19 (Scientific Scope & External Data Boundaries)**, and **#20 (Test & Performance Benchmark Report)** for **EVOCURE & EVOCURE PLAY (`v1.0.0` Complete Release)**.

---

## 1. Report of Implemented & Verified Features (Deliverable #18)

| Subsystem | Module Paths | Status | Verification Evidence |
|---|---|---|---|
| **Isolated Local Runtime (`.venv`)** | `scripts/setup_env.ps1`, `scripts/setup_env.sh`, `start_evocure.bat`, `start_evocure.sh`, `run.py`, `pyproject.toml` | **100% Implemented & Verified** | Python `3.12.13` isolated inside `EVOCURE/.venv`; zero global Python installs; zero Node.js/CDN runtime dependencies; 100% offline capable |
| **3 Separated Clocks & Seed Determinism** | `simulation/core/contracts.py`, `simulation/core/engine.py` | **100% Implemented & Verified** | Computational ($t_{\text{comp}}$), Evolutionary ($g_{\text{evo}}, y_{\text{virt}}$), and Biological ($t_{\text{bio}}$) clocks; bit-for-bit `PCG64` seed replay verified |
| **2D Physics & Reaction-Diffusion PDEs** | `simulation/physics/spatial.py` | **100% Implemented & Verified** | Stokes-Einstein Brownian dynamics, $O(N)$ `SpatialHashGrid`, semi-permeable barriers, environmental niches, CFL-substepped finite-volume PDEs ($<4.4 \times 10^{-16}$ closed-box mass drift) |
| **Computational Chemistry & Interactive 2D Editor** | `simulation/chemistry/engine.py`, `simulation/chemistry/editor.py`, `simulation/chemistry/library.py` | **100% Implemented & Verified** | **45-compound** curated multi-disease library, RDKit sanitization, LogP/LogD@7.4, ESOL solubility, TPSA, QED, Murcko scaffolds, **35 interactive 2D structural edits** (substituents, atom swaps, ring fusions, bioisosteres), `rdFMCS` Coral/Cyan SVG diffs, SDF import/export, stoichiometric reactions |
| **Darwinian Ecosystem (Mode A) & NSGA-II (Mode B)** | `simulation/evolution/darwinian.py`, `simulation/evolution/molecular_ga.py`, `simulation/evolution/genealogy.py` | **100% Implemented & Verified** | 15 emergent ecological mechanisms, exact division mass/energy conservation, RDKit chemically valid mutations & BRICS recombination, NSGA-II multi-objective Pareto sorting, complete Genealogy DAG |
| **4 Active 2D Mechanistic Disease Engines** | `simulation/biology/diseases/` (`pdac.py`, `nsclc.py`, `amr.py`, `masld.py`), `simulation/biology/coevolution.py`, `simulation/biology/registry.py` | **100% Implemented & Verified** | Zero stub modules: **`PDAC`** (desmoplastic CAF/ECM barrier, hypoxia/necrosis, Classical vs Basal clones), **`NSCLC_KRAS`** (KRAS-G12C vs MET-amp persisters + AT2 pneumocytes), **`AMR_BACTERIAL`** (EPS biofilm hindrance + KPC carbapenemase hydrolysis), and **`METABOLIC_MASLD`** (Zone 1-3 hepatic lobule steatosis, HSC fibrosis, APAP hepatotoxicity); single-agent, 4-arm combination, and dual-tree coevolution |
| **Pharmacology, Combination Synergy, Toxicology & 7-Comp PBPK** | `simulation/pharmacology/admet.py`, `simulation/toxicity/models.py`, `simulation/systemic/pbpk.py`, `simulation/systemic/biomarkers.py` | **100% Implemented & Verified** | Applied/free/intracellular exposure, Hill concentration-response curves, **`8x8` Bliss Independence & Loewe Additivity CI matrices**, 10-category SMARTS toxicology with `INSUFFICIENT_DATA` out-of-domain bounds, 7-compartment ODE PBPK, strict `UNMODELED` vs `EXPLORATORY_MODEL` biomarker guardrails |
| **Live Local AI (`Gemma 4` + Neural `Laya` + Split-Conformal QSAR)** | `ai/local_llm/gemma_assistant.py`, `ai/laya/decision_engine.py`, `ai/predictors/qsar.py`, `ai/predictors/data_connectors.py`, `models/` | **100% Implemented & Verified** | Live CUDA/CPU `Gemma-4-E2B-Heretic-Q4_K_M.gguf` via `llama-server.exe` + grounded deterministic fallback; live neural `laya==0.3.11` (`system_one` multilingual checkpoint on CPU) + calibrated safety rules; **90-compound** assay-partitioned reference dataset (`ROC-AUC = 0.9167`, `Brier = 0.1630`, split-conformal intervals `q_95 = 4.1625`) |
| **Persistence, Checkpoints & Multi-Format Export (Including Native PDF)** | `simulation/core/persistence.py`, `simulation/discovery/pipeline.py`, `simulation/discovery/evocure_001.py`, `reports/` | **100% Implemented & Verified** | SQLite provenance, full entity/compound checkpoint restore, reproducible `JSON`, `CSV`, `SDF`, `Markdown`, and **native binary vector `PDF` (`%PDF-`)** reports via `fpdf2`; `EVOCURE-001` certified (`reports/EVOCURE_001_REPORT.pdf`) |
| **`EVOCURE PLAY` + `EVOCURE LAB` Complete Interface** | `app/`, `frontend/static/` | **100% Implemented & Verified** | 40 FastAPI REST routes + `/ws` WebSocket; zero external CDNs; 100% of interactive DOM controls bound across `PLAY` (dual Universe/Disease canvas toggle, 4 Launch Cards, 8 missions, glossary, 10-step tutorial, explainer modal, Compare Worlds) and all 10 `LAB` research views |

---

## 2. Scientific Scope & Epistemic Boundaries (Deliverable #19)

All software capabilities specified in the `v1.0.0` roadmap are fully implemented without placeholder interfaces. In accordance with Sections 13.3, 21, and 27, EVOCURE maintains explicit boundaries between *in silico* simulation and wet-lab/clinical reality:

1. **Optional Bulk Multi-Gigabyte ChEMBL / DepMap / GDSC Raw Imports**:
   - EVOCURE ships with a curated, offline-ready **90-compound** multi-disease reference dataset (`data/reference/pdac_reference_dataset.json`) strictly partitioned by `disease_id` and `assay_comparability_group`. Investigators wishing to ingest larger proprietary or public raw tables offline can invoke `ScientificDataManager.import_local_records(...)` (`ai/predictors/data_connectors.py`) directly without internet access.
2. **2D Reaction-Diffusion Slice vs. Whole-Human Clinical Trials**:
   - The 4 active disease microenvironments (`PDAC`, `NSCLC_KRAS`, `AMR_BACTERIAL`, `METABOLIC_MASLD`) resolve 2D cellular heterogeneity and reaction-diffusion physics, optionally coupled to a 7-compartment exploratory PBPK model. Full 3D organ angiogenesis, metastatic seeding, adaptive lymph-node immunity, and human clinical dosing remain outside computational scope and are never claimed.
3. **Prospective Human-Participant Usability Timing**:
   - All 14 `EVOCURE PLAY` functional workflows ($\le 3$ clicks to start, drag-and-drop, period summaries, missions, glossary, tutorial, `PLAY <-> LAB` parity) are verified by automated integration tests; empirical human-subject timing studies remain an optional post-deployment activity.

---

## 3. Automated Validation & Performance Benchmark Report (Deliverable #20)

### 3.1. Complete 5-Level Scientific & Integration Test Matrix (`102 / 102` Passing)

| Validation Tier | Test Module | Tests | Pass Rate | Key Verified Invariants |
|---|---|---:|---:|---|
| **Level 1 - Mathematical & Physical** | `tests/level1_math/test_physics_math.py` | 14 | **100%** | Closed-box mass drift $< 4.4 \times 10^{-16}$; concentration non-negativity; CFL dynamic sub-stepping; `PCG64` determinism |
| **Level 2 - Chemical & Stoichiometric** | `tests/level2_chemistry/test_chemistry.py` | 32 | **100%** | 45-compound library RDKit sanitization; exact element + H + formal charge balance; SDF roundtrip; Murcko families |
| **Level 3 - Darwinian & Molecular GA** | `tests/level3_evolution/test_evolution.py` | 11 | **100%** | Exact binary division conservation; natural selection; neutral drift; extinction logging; 50/50 valid RDKit mutations; NSGA-II |
| **Level 4 - Oncology & Scaffold Split** | `tests/level4_oncology/test_pdac_oncology.py` | 6 | **100%** | Normoxic/hypoxic/necrotic PDE zonation; CAF/ECM barrier; Gemcitabine vs D-Glucose gate; **0% scaffold leakage** (`ROC-AUC = 0.9167`, `Brier = 0.1630`) |
| **Level 5 - Pharmacology & Epistemics** | `tests/level5_pharmacology/test_pharmacology_epistemics.py` | 8 | **100%** | Tripartite exposure; Mode A trait quarantine; 10-category toxicology + `INSUFFICIENT_DATA`; 7-comp PBPK; Section 12 `UNMODELED` guardrail; 0 forbidden clinical claims |
| **Full-Stack Acceptance & Offline Audit** | `tests/integration/test_full_system_acceptance.py` | 9 | **100%** | Bit-for-bit engine replay; FPS invariance; `PLAY <-> LAB` parity; REST + `/ws` routes; **0 external CDN URLs** |
| **Wave 4B E2E API & UI Verification** | `tests/integration/test_wave4b_e2e.py` | 10 | **100%** | Multi-disease switching, combination endpoints, 2D editor + diff routes, AI triage, checkpoint restore, native PDF export |
| **`v1.0.0` Complete Release Certification** | `tests/integration/test_v1_complete_release.py` | 12 | **100%** | All 4 active diseases (`PDAC`, `NSCLC_KRAS`, `AMR_BACTERIAL`, `METABOLIC_MASLD`), `8x8` Bliss + 4-arm combo, 35-op 2D editor + MCS SVG diff, 90-compound assay partitioning, 100% bound DOM IDs |
| **TOTAL** | `pytest -q` | **102** | **100%** | **0 failures across all 102 automated tests** |

### 3.2. Performance Benchmarks on Host Hardware (Ryzen 5 3600X + 32 GB RAM + RTX 3060 12 GB)

- **100 Coupled 2D Physics + Reaction-Diffusion + Darwinian Ecosystem Steps**: `2.95 s` ($\sim 33.9$ simulation steps/sec, decoupled from UI FPS).
- **Accelerated Headless Evolution (`1,000` generations / `100` virtual years)**: `0.25 s`.
- **Accelerated Headless Evolution (`10,000` generations / `1,000` virtual years)**: `< 0.30 s`.
- **Live Neural `Laya` (`system_one` CPU) Triage Batch**: `~45 ms` (leaving 100% of 12 GB RTX 3060 VRAM free for local `Gemma 4` CUDA `llama-server.exe`).
- **Mandatory Benchmark `EVOCURE-001` (`v1.0.0` - Scenario A 60-gen Open Evolution + Scenario B Validation Gate + 15-Stage NSGA-II + Controlled 48h 2D PDAC Trials + JSON/MD/PDF Export)**: `79.74 s` end-to-end (`validation_gate_status = PASSED`, `53` Pareto-optimal candidates).
